Capital Impact Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
Capital Impact Advisors, LLC
- $34.9 Million
- Q2 2024
A detailed history of Capital Impact Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Capital Impact Advisors, LLC holds 13,925 shares of BBIO stock, worth $356,897. This represents 1.01% of its overall portfolio holdings.
Number of Shares
13,925
Previous 14,762
5.67%
Holding current value
$356,897
Previous $456,000
22.81%
% of portfolio
1.01%
Previous 0.61%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$796 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$644 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$360 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$319 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$156 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.8B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...